Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase

Journal of Nutritional Biochemistry

Volumn 25, Issue 4, 2014, Pages 463-474

  Cong, Weitao ^a   Zhao, Ting ^a   Zhu, Zhongxin ^a   Huang, Binbin ^a   Ma, Weide ^b   Wang, Yuehui ^c   Tan, Yi ^a,d   Chakrabarti, Subrata ^e   Li, Xiaokun ^a   Jin, Litai ^a   Cai, Lu ^a,d  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU PEOPLE'S HOSPITAL   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^e WESTERN UNIVERSITY   (Canada)

Author keywords

ATP synthase subunit; ATP synthase subunit; Diabetic cardiomyopathy; Metallothionein; Nitration

Indexed keywords

METALLOTHIONEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; STREPTOZOCIN; TYROSINE; ZINC; PROTEIN SUBUNIT; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME SUBUNIT; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NITRATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SUBUNIT; PROTEOMICS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SUPPLEMENTATION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; DIET SUPPLEMENTATION; ENZYME ACTIVATION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART MUSCLE; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; ENZYME ACTIVATION; MALE; METALLOTHIONEIN; MICE, TRANSGENIC; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MYOCARDIUM; PROTEIN SUBUNITS; STREPTOZOCIN; SUPEROXIDES; TYROSINE; ZINC;

EID: 84896820798     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.12.007     Document Type: Article

References (50)

1. Duncan J.G. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 1813, 2011:1351-1359.
2. Cai L. Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications. Curr Med Chem. 2007, 14:2193-2203.
3. Nath R., Kumar D., Li T., Singal P.K. Metallothioneins, oxidative stress and the cardiovascular system. Toxicology. 2000, 155:17-26.
4. Cai L., Wang Y., Zhou G., Chen T., Song Y., Li X., et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol. 2006, 48:1688-1697.
5. 2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med. 2006, 40:1419-1429.
6. Ye G., Metreveli N.S., Ren J., Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes. 2003, 52:777-783.
7. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 2002, 51:174-181.
8. Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med 2006, 41:851-861.
9. Wang J., Song Y., Elsherif L., Song Z., Zhou G., Prabhu S.D., et al. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 2006, 113:544-554.
10. Cai L., Wang J., Li Y., Sun X., Wang L., Zhou Z., et al. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 2005, 54:1829-1837.
11. Abrahams J.P., Leslie A.G., Lutter R., Walker J.E. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria. Nature 1994, 370:621-628.
12. Jana N.R., Tanaka M., Wang G., Nukina N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum Mol Genet 2000, 9:2009-2018.
13. Terni B., Boada J., Portero-Otin M., Pamplona R., Ferrer I. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology. Brain Pathol 2010, 20:222-233.
14. Fujisawa Y., Kato K., Giulivi C. Nitration of tyrosine residues 368 and 345 in the beta-subunit elicits FoF1-ATPase activity loss. Biochem J 2009, 423:219-231.
15. Kane L.A., Youngman M.J., Jensen R.E., Van Eyk J.E. Phosphorylation of the F(1)F(o) ATP synthase beta subunit: functional and structural consequences assessed in a model system. Circ Res 2010, 106:504-513.
16. Hojlund K., Wrzesinski K., Larsen P.M., Fey S.J., Roepstorff P., Handberg A., et al. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 2003, 278:10436-10442.
17. Yin T., Hou R., Liu S., Lau W.B., Wang H., Tao L. Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol 2010, 49:354-361.
18. Cong W.T., Ling J., Tian H.S., Ling R., Wang Y., Huang B.B., et al. Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury. Can J Physiol Pharmacol 2013, 91:973-984.
19. Xu J., Wang G., Wang Y., Liu Q., Xu W., Tan Y., et al. Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection. J Cell Mol Med 2009, 13:1499-1512.
20. Bachschmid M.M., Xu S., Maitland-Toolan K.A., Ho Y.S., Cohen R.A., Matsui R. Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice. Free Radic Biol Med 2010, 49:1221-1229.
21. Zheng J., Ramirez V.D. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Biochem Biophys Res Commun 1999, 261:499-503.
22. Manfredi G., Yang L., Gajewski C.D., Mattiazzi M. Measurements of ATP in mammalian cells. Methods 2002, 26:317-326.
23. Jin L.T., Li X.K., Cong W.T., Hwang S.Y., Choi J.K. Previsible silver staining of protein in electrophoresis gels with mass spectrometry compatibility. Anal Biochem 2008, 383:137-143.
24. Wang Y., Feng W., Xue W., Tan Y., Hein D.W., Li X.K., et al. Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling. Diabetes 2009, 58:1391-1402.
25. Zhou G., Li X., Hein D.W., Xiang X., Marshall J.P., Prabhu S.D., et al. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol 2008, 52:655-666.
26. Haynes V., Traaseth N.J., Elfering S., Fujisawa Y., Giulivi C. Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging. Am J Physiol Endocrinol Metab 2010, 298:E978-E987.
27. Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968, 7:4030-4034.
28. Wang Y., Peng F., Tong W., Sun H., Xu N., Liu S. The nitrated proteome in heart mitochondria of the db/db mouse model: characterization of nitrated tyrosine residues in SCOT. J Proteome Res 2010, 9:4254-4263.
29. Gianazza E. Isoelectric focusing as a tool for the investigation of post-translational processing and chemical modifications of proteins. J Chromatogr A 1995, 705:67-87.
30. Zhu K., Zhao J., Lubman D.M., Miller F.R., Barder T.J. Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins. Anal Chem 2005, 77:2745-2755.
31. Yang M., Camara A.K., Wakim B.T., Zhou Y., Gadicherla A.K., Kwok W.M., et al. Tyrosine nitration of voltage-dependent anion channels in cardiac ischemia-reperfusion: reduction by peroxynitrite scavenging. Biochim Biophys Acta 1817, 2012:2049-2059.
32. Liu Y., Ma Y., Wang R., Xia C., Zhang R., Lian K., et al. Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells. Antioxid Redox Signal. 2011, 15:1769-1778.
33. Cai L., Satoh M., Tohyama C., Cherian M.G. Metallothionein in radiation exposure: its induction and protective role. Toxicology. 1999, 132:85-98.
34. Cai L., Klein J.B., Kang Y.J. Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem. 2000, 275:38957-38960.
35. Jiang S., Guo R., Zhang Y., Zou Y. Heavy metal scavenger metallothionein mitigates deep hypothermia-induced myocardial contractile anomalies: role of autophagy. Am J Physiol Endocrinol Metab. 2013, 304:E74-E86.
36. Yang H.Y., Wang Y.M., Peng S.Q. Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage. Toxicon 2010, 55:1291-1296.
37. Zhang Y., Hu N., Hua Y., Richmond K.L., Dong F., Ren J. Cardiac overexpression of metallothionein rescues cold exposure-induced myocardial contractile dysfunction through attenuation of cardiac fibrosis despite cardiomyocyte mechanical anomalies. Free Radic Biol Med 2012, 53:194-207.
38. Cross R.L., Cunningham D., Miller C.G., Xue Z.X., Zhou J.M., Boyer P.D. Adenine nucleotide binding sites on beef heart F1 ATPase: photoaffinity labeling of beta-subunit Tyr-368 at a noncatalytic site and beta Tyr-345 at a catalytic site. Proc Natl Acad Sci U S A 1987, 84:5715-5719.
39. Sultana R., Poon H.F., Cai J., Pierce W.M., Merchant M., Klein J.B., et al. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 2006, 22:76-87.
40. Lee H.M., Reed J., Greeley G.H., Englander E.W. Impaired mitochondrial respiration and protein nitration in the rat hippocampus after acute inhalation of combustion smoke. Toxicol Appl Pharmacol 2009, 235:208-215.
41. Liu B., Tewari A.K., Zhang L., Green-Church K.B., Zweier J.L., Chen Y.R., et al. Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta 2009, 1794:476-485.
42. Zhang Y., Yang H., Poschl U. Analysis of nitrated proteins and tryptic peptides by HPLC-chip-MS/MS: site-specific quantification, nitration degree, and reactivity of tyrosine residues. Anal Bioanal Chem 2011, 399:459-471.
43. Berlett B.S., Friguet B., Yim M.B., Chock P.B., Stadtman E.R. Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction. Proc Natl Acad Sci U S A 1996, 93:1776-1780.
44. Lambert C., Leonard N., De Bolle X., Depiereux E. ESyPred3D: prediction of proteins 3D structures. Bioinformatics 2002, 18:1250-1256.
45. Li B., Tan Y., Sun W., Fu Y., Miao L., Cai L. The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. Toxicol Mech Methods 2013, 23:27-33.
46. Gupta R., Garg V.K., Mathur D.K., Goyal R.K. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India 1998, 46:939-942.
47. Miao X., Sun W., Fu Y., Miao L., Cai L. Zinc homeostasis in the metabolic syndrome and diabetes. Front Med 2013, 7:31-52.
48. Sullivan V.K., Burnett F.R., Cousins R.J. Metallothionein expression is increased in monocytes and erythrocytes of young men during zinc supplementation. J Nutr 1998, 128:707-713.
49. Cao J., Cousins R.J. Metallothionein mRNA in monocytes and peripheral blood mononuclear cells and in cells from dried blood spots increases after zinc supplementation of men. J Nutr 2000, 130:2180-2187.
50. Zhou Z., Wang L., Song Z., Saari J.T., McClain C.J., Kang Y.J. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 2005, 166:1681-1690.